Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Money laundering case: ED custody of Sterling Biotechs director extended till Feb 7

      Money laundering case: ED custody of Sterling Biotech's director extended till Feb 7

      Ruby Khatun Khatun30 Jan 2018 10:15 AM IST
      New Delhi: A Delhi court has extended till February 7 the Enforcement Directorate custody of a director of a Gujarat-based pharma firm in a money...
      HealthCare at Home to hire around 4,500 persons in India by FY19-end

      HealthCare at Home to hire around 4,500 persons in India by FY19-end

      Ruby Khatun Khatun30 Jan 2018 10:00 AM IST
      New Delhi: Home healthcare service provider HealthCare at Home (HCAH) plans to hire around 4,500 employees by the end of next fiscal as it undertakes...
      Billionaire Singh brothers accused in lawsuit of siphoning money: Bloomberg Report

      Billionaire Singh brothers accused in lawsuit of siphoning money: Bloomberg Report

      Ruby Khatun Khatun29 Jan 2018 4:17 PM IST
      India’s billionaire Singh brothers, already embroiled in one international legal battle over alleged fraud, are being accused of "diversion, siphoning...
      SMT announces positive results from the S flex UK Registry

      SMT announces positive results from the S flex UK Registry

      Ruby Khatun Khatun29 Jan 2018 10:15 AM IST
      Mumbai / London: SMT (Sahajanand Medical Technologies Pvt. Ltd.), India’s largest manufacturer of cardiovascular medical stents, announced the...
      Roche hemophilia drug lowers costs despite high price: ICER

      Roche hemophilia drug lowers costs despite high price: ICER

      Ruby Khatun Khatun29 Jan 2018 10:00 AM IST
      A costly new Roche Holding AG drug to treat the bleeding disorder hemophilia A could significantly reduce healthcare expenses for certain patients, a...
      New Rules on Clinical trials: Pharma Cos to pay for Injuries, Death of Participants

      New Rules on Clinical trials: Pharma Cos to pay for Injuries, Death of Participants

      Ruby Khatun Khatun28 Jan 2018 12:17 PM IST
      The new draft rules for clinical trials and new drugs in India that are impending legislation in the country will put more responsibility on the...
      Essential affordable severely lacking in Indian pharma: Global Health study

      Essential affordable severely lacking in Indian pharma: Global Health study

      Ruby Khatun Khatun28 Jan 2018 10:31 AM IST
      Research has revealed the shocking lack of access to essential medicines in India, despite thousands being approved in an attempt to generate wider...
      Generic Drug Name to be two font larger than Brand Name: New Labelling Rules

      Generic Drug Name to be two font larger than Brand Name: New Labelling Rules

      Ruby Khatun Khatun27 Jan 2018 1:56 PM IST
      New Delhi: Labeling rules for generic drugs are going to become stringent on order to endorse low-cost generic medicines as the health ministry is...
      Biocon net profit plunges 46 percent in Q3

      Biocon net profit plunges 46 percent in Q3

      Ruby Khatun Khatun27 Jan 2018 11:00 AM IST
      New Delhi: Shares of biotechnology major Biocon dropped by over 4 percent after the company reported a 46.35 percent dip in consolidated net profit...
      Patanjali accuses Kalpamrit Ayurveda of copyright violations, Battle In High Court

      Patanjali accuses Kalpamrit Ayurveda of copyright violations, Battle In High Court

      Ruby Khatun Khatun26 Jan 2018 5:45 PM IST
      New Delhi: Patanjali Ayurved has pulled its former partner to Delhi high court for allegedly violating its trademark and copyrights.Patanjali has...
      Johnson and Johnson takes 13.6 billion dollars charge related to new US tax law

      Johnson and Johnson takes 13.6 billion dollars charge related to new US tax law

      Ruby Khatun Khatun25 Jan 2018 9:45 AM IST
      Healthcare conglomerate Johnson and Johnson on Tuesday took a $13.6-billion charge related to the new U.S. tax law and plans to bring back billions of...
      Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug

      Puma Biotechnology sinks after Europe unlikely to OK breast cancer drug

      Ruby Khatun Khatun25 Jan 2018 9:30 AM IST
      Puma Biotechnology Inc said a European regulatory panel indicated it was unlikely to provide a positive opinion on the company’s breast cancer drug,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok